Form 4 for IDXX Idexx Laboratories
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-12 · accession 0000874716-26-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-17 | 2026-02-14 | IDXX | FENNELL GEORGE | EVP | F - Tax | $629.35 | -199 | 10.1K | -2% | -$125.2K |
| DM | 2026-02-17 | 2026-02-14 | IDXX | FENNELL GEORGE | EVP | M - OptEx | $0.00 | +454 | 9,878 | +5% | $0 |
| DM | 2026-02-17 | 2026-02-12 | IDXX | FENNELL GEORGE | EVP | A - Grant | $0.00 | +4,356 | 810 | New | $0 |
| DM | 2026-02-17 | 2026-02-14 | IDXX | FENNELL GEORGE | EVP | M - OptEx | $0.00 | -454 | 612 | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-14 | F | D | 199 | $629.35 | 10,078 | D | — | — | (F1) Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026. |
| 2 | Common | Common Stock | 2026-02-14 | M | A | 204 | $0.00 | 10,277 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-14 | M | A | 139 | $0.00 | 10,073 | D | — | — | |
| 4 | Common | Common Stock | 2026-02-14 | M | A | 56 | $0.00 | 9,934 | D | — | — | |
| 5 | Common | Common Stock | 2026-02-14 | M | A | 55 | $0.00 | 9,878 | D | — | — | |
| 6 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2026-02-12 | A | A | 3,384 | $0.00 | 3,384 | D | $617.20 · — to 2036-02-11 | 3,384 Common Stock | (F2) Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027. |
| 7 | Derivative | Incentive Stock Option (right-to-buy) | 2026-02-12 | A | A | 162 | $0.00 | 162 | D | $617.20 · — to 2036-02-11 | 162 Common Stock | (F3) Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030. |
| 8 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 139 | $0.00 | 278 | D | — · — to — | 139 Common Stock | (F7) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025. |
| 9 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 56 | $0.00 | 56 | D | — · — to — | 56 Common Stock | (F6) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning February 14, 2024. |
| 10 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 55 | $0.00 | 0 | D | — · — to — | 55 Common Stock | (F5) Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments beginning February 14, 2023. |
| 11 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 204 | $0.00 | 612 | D | — · — to — | 204 Common Stock | (F8) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2026. |
| 12 | Derivative | Restricted Stock Unit | 2026-02-12 | A | A | 810 | $0.00 | 810 | D | — · — to — | 810 Common Stock | (F4) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock that vests in four annual installments, beginning February 14, 2027. |